SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001100412-18-000013
Filing Date
2018-06-25
Accepted
2018-06-25 09:01:51
Documents
7
Period of Report
2018-06-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 a6-258xkpressrelease6x25x2.htm 8-K 35756
2 EXHIBIT 99.1 arraybeaconesmogi62218fi.htm EX-99.1 16936
3 a6258kpressrelease625_image1.jpg GRAPHIC 146580
4 arraybeaconesmogi62218fi001.jpg GRAPHIC 238852
5 arraybeaconesmogi62218fi002.jpg GRAPHIC 288589
6 arraybeaconesmogi62218fi003.jpg GRAPHIC 267829
7 arraybeaconesmogi62218fi004.jpg GRAPHIC 156931
  Complete submission text file 0001100412-18-000013.txt   1567473
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 18916103
SIC: 2834 Pharmaceutical Preparations